Oakwood Labs at the 2024 Drug Delivery and Formulation Summit
Oakwood Labs is happy to announce that we will be at the 2024 Drug Delivery and Formulation Summit on September 17-18 in San Diego. If you would like to learn more about the event and register to attend, please visit the following link: https://ddfsummit.com/DDF2024/en/page/home
Company Overview
Oakwood Labs is a global leader in sustained release drug delivery. We support all phases of long acting injectable development from initial feasibility studies through FDA-approved clinical and commercial supply. Oakwood has 25 years of drug encapsulation experience using Chroniject™, our patented microsphere-based technology. Chroniject™ provides the ability to control particle size, customize release durations from weeks to years, and minimize residual solvents to achieve critical quality attributes.
Stop by Oakwood Lab’s Booth #20 to meet our team and learn more about how we can assist in the following areas:
- Long Acting Injectable Technology
- Feasibility studies
- Scale-up of formulation
- Manufacturing toxicology batches
- Clinical trial manufacturing (Phase I, II, III)
- Contract Manufacturing
- Technology Transfer
- GMP Registration and Validation batches
- Aseptic GMP commercial batch manufacturing
- ICH compliant stability testing
Contact Us for More Information
The DDF 2024 conference covers a wide range of topics, and we are happy to contribute to the event! If you aren’t able to attend, but still want to learn more about Oakwood Labs or what you missed at the conference, contact us today!
We look forward to discussing our technology and more.
- Opioid Use Disorder: Developing Long-Acting Injectables for Treatment - November 5, 2024
- Listen to Oakwood Labs Present Chroniject Technology at the 2024 PODD Conference - October 17, 2024
- Find Oakwood Labs at the 2024 AAPS PharmSci 360 - October 9, 2024